Press release
Recurrent Head and Neck Cancer Squamous Cell Carcinoma Market to Grow Positively at a Paltry CAGR | Companies- Sanofi, F. Hoffmann-La Roche, Boehringer Ingelheim International GmbH, GSK plc, Novartis AG, Bayer AG, Merck & Co
Recurrent Head and Neck Cancer Squamous Cell Carcinoma Market
Request for a Free Recurrent Head and Neck Cancer Squamous Cell Carcinoma Market Sample Report @ https://www.delveinsight.com/sample-request/recurrent-head-and-neck-cancer-squamous-cell-carcinoma-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Recurrent Head and Neck Cancer Squamous Cell Carcinoma Overview
Squamous cell carcinoma is a cancer that arises from particular cells called squamous cells. Squamous cells are found in the outer layer of skin and in the mucous membranes, which are the moist tissues that line body cavities such as the airways and intestines. Head and neck squamous cell carcinoma (HNSCC) develops in the mucous membranes of the mouth, nose, and throat.
HNSCC is classified by its location: it can occur in the mouth (oral cavity), the middle part of the throat near the mouth (oropharynx), the space behind the nose (nasal cavity and paranasal sinuses), the upper part of the throat near the nasal cavity (nasopharynx), the voicebox (larynx), or the lower part of the throat near the larynx (hypopharynx). Depending on the location, the cancer can cause abnormal patches or open sores (ulcers) in the mouth and throat, unusual bleeding or pain in the mouth, sinus congestion that does not clear, sore throat, earache, pain when swallowing or difficulty swallowing, a hoarse voice, difficulty breathing, or enlarged lymph nodes.
HNSCC can spread (metastasize) to other parts of the body, such as the lymph nodes or lungs. If it spreads, the cancer has a worse prognosis and can be fatal. About half of affected individuals survive more than five years after diagnosis.
Recurrent Head and Neck Cancer Squamous Cell Carcinoma Symptoms
Head and neck cancer can be hard to diagnose because symptoms are often mild and can mimic less serious conditions like a cold or sore throat. A sore throat that doesn't get better is the most common symptom of a head and neck cancer.
Symptoms include:
A persistent sore throat.
Frequent headaches.
Hoarseness or voice changes.
Pain when you chew or swallow.
Pain in your upper teeth.
Facial numbness or pain.
Neck pain that won't go away.
Trouble breathing or speaking.
A lump in your throat, mouth or neck.
Persistent earaches or infections.
Nosebleeds, bloody saliva or phlegm.
A mouth or tongue sore that doesn't heal.
Frequent sinus infections that don't respond to antibiotics.
A white or red patch on your gums, tongue or inside of your mouth.
Swelling in your jaw, neck or side of your face (that may cause your dentures to fit poorly).
Recurrent Head and Neck Cancer Squamous Cell Carcinoma Treatment
The three main treatments are surgery, radiation therapy and chemotherapy. Your healthcare provider may also recommend newer treatments like targeted therapy and immunotherapy or suggest you participate in a clinical trial.
Surgery: Surgeons may remove the tumor and a margin of surrounding healthy tissue. The surgeon may also remove the lymph nodes in your neck if they suspect the cancer's spread there.
Radiation therapy: The most common form of radiation for head and neck cancers uses a machine that directs high-energy X-rays toward your tumor (EBRT). You may receive radiation as a standalone treatment or alongside other treatments like surgery and chemotherapy. Radiation therapy can help relieve symptoms, too.
Chemotherapy: Chemotherapy uses a single drug or a combination of drugs to kill cancer cells. It's more commonly used for advanced-stage head and neck cancers.
Targeted therapy: These drugs target specific types of cancer. They're most often used in combination with other treatments to treat advanced head and neck cancers. Cetuximab (Erbitux®) is a drug that targets a tumor protein called epidermal growth factor (EGFR) and is U.S. Food and Drug Administration (FDA)-approved to treat particular head and neck cancers. There are treatments approved by the FDA specific to genetic changes, such as larotrectinib (Vitrakvi®), which is used to treat people with mutations in their NTRK gene.
Immunotherapy: Immunotherapy drugs activate (or boost) your immune system to identify and destroy cancer cells more effectively. Pembrolizumab (Keytruda®) and nivolumab (Opdivo®) are two FDA-approved immunotherapy drugs used to treat certain head and neck cancers that've spread or returned following treatment.
Request for a Free Recurrent Head and Neck Cancer Squamous Cell Carcinoma Market Sample Report @ https://www.delveinsight.com/report-store/recurrent-head-and-neck-cancer-squamous-cell-carcinoma-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Leading Companies Working in the Recurrent Head and Neck Cancer Squamous Cell Carcinoma Market
Sanofi
F. Hoffmann-La Roche
Boehringer Ingelheim International GmbH
GSK
Novartis AG
Bayer AG
Merck & Co
To understand key companies related to the Recurrent Head and Neck Cancer Squamous Cell Carcinoma Market, get a snapshot of the Recurrent Head and Neck Cancer Squamous Cell Carcinoma Regulatory and Patent Analysis @ https://www.delveinsight.com/sample-request/recurrent-head-and-neck-cancer-squamous-cell-carcinoma-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Scope of the Recurrent Head and Neck Cancer Squamous Cell Carcinoma Market Report
Study Period: 2019-2032
Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), Japan]
Key Recurrent Head and Neck Cancer Squamous Cell Carcinoma Companies: Sanofi, F. Hoffmann-La Roche, Boehringer Ingelheim International GmbH, GSK plc, Novartis AG, Bayer AG, Merck & Co., and others
Therapeutic Assessment: Recurrent Head and Neck Cancer Squamous Cell Carcinoma current marketed and emerging therapies
Recurrent Head and Neck Cancer Squamous Cell Carcinoma Market Dynamics: Recurrent Head and Neck Cancer Squamous Cell Carcinoma market drivers and barriers
Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
Unmet Needs, KOL's views, Analyst's views, Recurrent Head and Neck Cancer Squamous Cell Carcinoma Market Access and Reimbursement
Connect with our sales team to get your Recuurent Head and Neck Cancer Squamous Cell Carcinoma Market Report customised @ https://www.delveinsight.com/report-store/recurrent-head-and-neck-cancer-squamous-cell-carcinoma-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Table of Contents
1. Recurrent Head and Neck Cancer Squamous Cell Carcinoma Market Key Insights
2. Recurrent Head and Neck Cancer Squamous Cell Carcinoma Market Report Introduction
3. Recurrent Head and Neck Cancer Squamous Cell Carcinoma Market Overview at a Glance
4. Recurrent Head and Neck Cancer Squamous Cell Carcinoma Market Executive Summary
5. Disease Background and Overview
6. Recurrent Head and Neck Cancer Squamous Cell Carcinoma Treatment and Management
7. Recurrent Head and Neck Cancer Squamous Cell Carcinoma Epidemiology and Patient Population
8. Patient Journey
9. Recurrent Head and Neck Cancer Squamous Cell Carcinoma Emerging Drugs
10. 7MM Recurrent Head and Neck Cancer Squamous Cell Carcinoma Market Analysis
11. Recurrent Head and Neck Cancer Squamous Cell Carcinoma Market Outlook
12. Potential of Current and Emerging Therapies
13. KOL Views
14. Recurrent Head and Neck Cancer Squamous Cell Carcinoma Market Drivers
15. Recurrent Head and Neck Cancer Squamous Cell Carcinoma Market Barriers
16. Unmet Needs
17. SWOT Analysis
18. Appendix
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
Contact Us:
Name: Kritika Rehani
E-mail: info@delveinsight.com
Phone: +1(919)321-6187
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: NV 89107
Country: United States
Website: https://www.delveinsight.com
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Recurrent Head and Neck Cancer Squamous Cell Carcinoma Market to Grow Positively at a Paltry CAGR | Companies- Sanofi, F. Hoffmann-La Roche, Boehringer Ingelheim International GmbH, GSK plc, Novartis AG, Bayer AG, Merck & Co here
News-ID: 3130359 • Views: …
More Releases from DelveInsight Business
Familial Chylomicronemia Syndrome Market and Epidemiology 2034: Treatment Market …
DelveInsight's "Familial Chylomicronemia Syndrome Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Familial Chylomicronemia Syndrome, historical and forecasted epidemiology as well as the Familial Chylomicronemia Syndrome market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Familial Chylomicronemia Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Familial Chylomicronemia Syndrome…
More Releases for Head
Green Dot Sign® Going Head-to-Head with Traditional Plastic ADA Signs
After the success of their groundbreaking sustainable ADA compliant interior signs, Green Dot Sign® is now offering a more affordable and adaptable option than ever before: Low profile office signs.
Nussbaum started considering environmentally-friendly manufacturing methods and products while working at his prior sign company. The idea to create signage from a wood base and non-toxic 3D printed material for lettering, braille, and pictograms was sparked by a braille sign with…
China and India are growing head to head in Companion Diagnostic market
“Asia-Pacific Companion Diagnostics Market" research report, published by Market Data Forecast estimates that the market is growing with a CAGR of 27.91% to reach USD 2.17 billion by 2021, from USD 0.63 billion in 2016, which amounts to a cumulative growth of USD 1.54 billion.
A companion diagnostics device is a medical device that provides information which is necessary for drug safety and effectives or any other biological product. This helps…
East and West going head to head in Asia-Pacific Food Emulsifiers Market
Asia-Pacific Food Emulsifiers Market" research report, published by Market Data Forecast delineates that the market is growing with a CAGR of 6.15% to reach USD 0.78 billion by 2021, from USD 0.58 billion in 2016, which amounts to a cumulative growth of USD 0.20 billion.
View Full Report at http://www.marketdataforecast.com/market-reports/asia-pacific-food-emulsifiers-market-564/
Download Free Sample report at http://www.marketdataforecast.com/market-reports/asia-pacific-food-emulsifiers-market-564/request-sample
A substance used in food manufacturing which helps to combine liquids of different thicknesses is known as…
dinCloud Earns Top Marks in Head-to-Head Comparison
The #1 Brand in Hosted Virtual Desktops
LOS ANGELES, CA – June 19, 2012 – dinCloud, a cloud transformation company and provider of hosted virtual desktops, has come out on top as the leading provider of DaaS (Desktop as a Service) in a head-to-head comparison of five market leaders by ExtremeLabs. dinCloud’s solution received the groupings highest marks for the solution’s good control, as well as fast response, and was the…
University Students go head to head in University of Bolton’s “Sports Fiesta …
The University of Bolton Student’s Council and the Student Activities Department organized an integrated program of sporting activities around the theme "Sports Fiesta 2012" which drew a number of Universities from the Northern Emirates and Dubai.
The activities took place at UOB RAK Campus. Separate activities for male and female attendees included; badminton, basketball, chess, cricket, darts, tug-o-war, sprint race, football and volleyball matches, and other recreational games.
To coincide with the…
KnowledgetoAction Departments Go Head to Head in a Bowling Competition
London, UK ( ) October 25, 2010 - Employees of KnowledgetoAction (http://knowledgeandaction.co.uk) have been going head to head against each other in a series of team building competitions that began on September 1, 2010. Knowledge to Action believes strongly in team building and this event showcased their desire for excellent team cooperation and communication between departments, allowing for more cohesiveness within Knowledge to Action.
Most recently, each of the KnowledgetoAction…
